Nymox Pharmaceutical Corp/ BSP733981026 /
2023-07-06 10:00:00 PM | Chg. - | Volume | Bid11:38:32 PM | Ask12:10:27 AM | High | Low |
---|---|---|---|---|---|---|
0.2000USD | - | 932,736 Turnover: 147,318.8509 |
0.1766Bid Size: 100 | 0.1767Ask Size: 28,600 | 0.2200 | 0.1827 |
GlobeNewswire
03-27
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and...
GlobeNewswire
2023-11-30
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutle...
GlobeNewswire
2023-11-21
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California ...
GlobeNewswire
2023-11-03
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Acc...
GlobeNewswire
2023-11-03
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley,...
GlobeNewswire
2023-11-02
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Me...
GlobeNewswire
2023-10-31
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Impro...
GlobeNewswire
2023-10-27
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Impro...
GlobeNewswire
2023-09-25
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM)...
GlobeNewswire
2023-09-07
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc...
GlobeNewswire
2022-03-03
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate